FDA Device Intelligence
HomeEL.EN. SPA › DEKA SMARTXIDE²

DEKA SMARTXIDE²

EL.EN. SPA · Model M103J1 · UDI-DI 08057017760252

GEX Prescription
1
510(k) clearances
44,032
Adverse events (107 deaths)
201
Recalls
485
Facilities

Description

The DEKA SmartXide² system is a medical laser system equipped with a 80W CO2 laser source and an (optional) 980nm or 940nm 50W diode laser source. The CO2 laser radiation has a wavelength of 10600nm and is delivered to the treatment area through an articulated arm and a delivery accessory connected to its distal end.The DEKA SmartXide² CO2 laser can be used with DEKA CO2 scanning units and the DEKA EasySpot Hybrid micromanipulator. The diode laser source can be provided in two alternative wavelengths: 940nm and 980nm. The diode laser radiation is delivered to the treatment area through optical fibers, which are guided to the target tissue with the aid of handpieces.

Recalls

DateFirmReason
2026-08-06Lutronic CorporationUtilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
2026-05-05IPG Medical CorporationSoftware anomaly that causes a false display of error code 5018.
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-01-27Lutronic CorporationReports of devices sparking/popping and potentially burning patients.
2025-12-15LEASEIR TECHNOLOGIES SLUThe console label for affected devices is missing the "DANGER" symbol.
2025-07-22LUMENIS, LTD.The potential for unsterilized product within finished product labeled as sterile.
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.